Anti-Inflammatory Medication Guidelines for the Elderly

Primary Recommendation: Acetaminophen

The American Geriatrics Society recommends acetaminophen as the initial pharmacotherapy for musculoskeletal pain in older adults due to its superior safety profile compared to NSAIDs, lacking gastrointestinal bleeding, renal toxicity, and cardiovascular risks 2
Acetaminophen should be optimized to full therapeutic dosing (1000 mg per dose, up to 4000 mg daily) before considering any NSAID escalation, as it demonstrates non-inferiority to NSAIDs for minor musculoskeletal trauma and provides effective pain relief without hemodynamic compromise 1, 3, 4

If acetaminophen fails at maximum dosing, NSAIDs may be considered only with mandatory gastroprotection and strict patient selection, as they pose significant risks, including gastrointestinal bleeding, renal toxicity, and cardiovascular complications 1, 2, 3
The American College of Cardiology and other guideline societies recommend using the lowest effective dose for the shortest duration possible (ideally ≤2 weeks for acute conditions) to minimize these risks 1, 3, 4

Active peptic ulcer disease is an absolute contraindication for NSAID use, as it significantly increases the risk of gastrointestinal complications 3
Severe renal impairment (low creatinine clearance or chronic kidney disease) is also a contraindication, as NSAIDs can further compromise renal function 1, 4, 5

All elderly patients taking oral NSAIDs must receive a proton pump inhibitor (PPI) for gastrointestinal protection, as recommended by the American Gastroenterological Association 1, 3, 4, 5

NSAIDs are associated with a significant risk of adverse drug reactions, including gastrointestinal complications, renal toxicity, and cardiovascular events, with an estimated 100,000 hospitalizations annually in the United States 6
The relative risk of developing serious GI complications is 3- to 5-fold greater among NSAID users than nonusers, highlighting the need for caution and careful patient selection 6

For neuropathic or radicular pain components, gabapentin or duloxetine should be added to acetaminophen, as NSAIDs are ineffective and should not be used as monotherapy 3, 4, 5

Opioids should NOT be prescribed as first-line therapy for chronic pain in elderly patients due to increased risk of cognitive impairment, falls, respiratory depression, and addiction, as recommended by the American Geriatrics Society 5
Muscle relaxants and benzodiazepines should also be avoided due to high sedation risk, confusion, and falls, with minimal evidence for chronic pain 4, 5

Monitor renal function (serum creatinine, eGFR) every 3-6 months, or 1-2 weeks after starting NSAIDs, to minimize the risk of renal toxicity 4, 5
Assess blood pressure, signs of GI bleeding, and fluid retention/edema at each visit, and discontinue NSAIDs immediately if signs of renal dysfunction, GI bleeding, or cardiovascular complications develop 1, 4, 5